Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
taVNS in Dry Eye Disease
NCT04673643Phase 2Recruiting
- Sponsor
- Beijing Tongren Hospital
- Start
- Jul 2021
- Primary completion
- Oct 2024
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in dry eye disease (DED), sponsored by Beijing Tongren Hospital. Primary endpoint: Ocular Surface Disease Index at 6 months. Started Jul 2021; status: recruiting.
02
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT04673643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04673643.